Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	125.14	127.67	135.55	66.33	77.62	76.19
Short-Term Investments	296.55	255.67	232.67	365.34	145.92	364.51
Cash & Short-Term Investments	421.68	383.33	368.22	431.67	223.54	440.7
Cash Growth	10.87%	4.10%	-14.70%	93.11%	-49.28%	59.69%
Accounts Receivable	69.63	53.98	41.12	31.06	27.63	26.2
Other Receivables	-	-	14	15.8	1.4	1.3
Receivables	69.63	53.98	55.12	46.86	29.03	27.5
Inventory	12.35	12.41	7.73	6.1	4.99	4.91
Prepaid Expenses	22.98	9.49	4.32	14.62	8.92	5.4
Other Current Assets	14.49	12.39	23.24	-	-	-
Total Current Assets	541.13	471.6	458.64	499.25	266.46	478.5
Property, Plant & Equipment	6.87	8.01	0.32	1.78	1.52	4.18
Long-Term Investments	102.56	219.83	57.18	4.95	112.28	36.2
Long-Term Deferred Tax Assets	153	130.91	90.61	61.47	27.46	31.6
Other Long-Term Assets	20.05	10.19	14.79	15.99	16.05	21.25
Total Assets	823.61	840.55	621.52	583.43	423.76	571.73
Accounts Payable	34.45	15.38	17.4	11.98	6.91	10.55
Accrued Expenses	125.86	122.11	70.49	44.52	39.3	34.69
Current Portion of Leases	1.05	0.83	0.15	1.14	0.53	2.05
Current Income Taxes Payable	-	0.19	1.81	0.09	0.51	-
Other Current Liabilities	10.91	2.27	14.65	14.76	0.3	0.2
Total Current Liabilities	172.27	140.77	104.51	72.49	47.54	47.49
Long-Term Leases	5.31	6.11	-	-	-	0.5
Other Long-Term Liabilities	14.13	14.08	10.31	9.1	0.41	0.4
Total Liabilities	191.71	160.96	114.81	81.59	47.95	48.39
Common Stock	0.14	0.14	0.13	0.13	0.13	0.12
Additional Paid-In Capital	933.61	832.11	738.52	662.34	591.35	516.14
Retained Earnings	619.1	543.74	402.53	296.39	194.97	82.46
Treasury Stock	-923.29	-696.17	-635.08	-456.15	-410.41	-75.8
Comprehensive Income & Other	2.34	-0.22	0.61	-0.87	-0.23	0.42
Shareholders' Equity	631.9	679.59	506.71	501.84	375.81	523.34
Total Liabilities & Equity	823.61	840.55	621.52	583.43	423.76	571.73
Total Debt	6.36	6.94	0.15	1.14	0.53	2.55
Net Cash (Debt)	517.88	596.23	425.25	435.48	335.29	474.34
Net Cash Growth	-4.25%	40.21%	-2.35%	29.88%	-29.32%	52.10%
Net Cash Per Share	4.32	5.25	3.81	3.76	2.66	3.82
Filing Date Shares Outstanding	105.19	105.5	103.52	107.9	105.96	117.31
Total Common Shares Outstanding	105.12	105.11	103.41	107.84	105.94	116.74
Working Capital	368.87	330.83	354.13	426.76	218.92	431.01
Book Value Per Share	6.01	6.47	4.90	4.65	3.55	4.48
Tangible Book Value	631.9	679.59	506.71	501.84	375.81	523.34
Tangible Book Value Per Share	6.01	6.47	4.90	4.65	3.55	4.48
Machinery	-	-	-	-	1.16	0.81
Leasehold Improvements	-	-	-	-	1.26	1.23

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q